| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Eastham Karin serves as a Director at GERN and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 46 sells. Those positions are worth an estimated $4.1M at current prices.
Historically, Eastham Karin's trades have earned a middling insider score of 65/100 across 16 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +7.2%.
The biggest single holding is ILMN (~$3.2M) as Director. The recent filings there lean toward selling, a net 6,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | VCYT Veracyte, Inc. | Director | Sale+OE | 18,750 | $22.78 | $427,044.38 | -44.4% | +13.3% | -9.5% | |
| Feb 28, 2023 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $25.00 | $250,001.00 | -29.9% | +4.3% | -3.4% | |
| Sep 13, 2022 | NKTR Nektar Therapeutics | Director | Sell | 21,267 | $3.61 | $76,773.87 | -62.0% | -23.7% | -80.6% | |
| Dec 17, 2021 | VCYT Veracyte, Inc. | Director | Sale+OE | 5,000 | $45.00 | $225,000.00 | -36.4% | -38.7% | -39.1% | |
| Nov 1, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,400 | $32,978.71 | $145,106,339.40 | -100% | -41.3% | -60.1% | |
| Aug 2, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,400 | $43.91 | $193,193.91 | -50.0% | +17.9% | -39.4% | |
| May 3, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,427 | $48.27 | $213,699.64 | -33.5% | -4.5% | -53.3% | |
| Feb 25, 2021 | VCYT Veracyte, Inc. | Director | Sale+OE | 6,250 | $60.70 | $379,358.58 | - | - | - | |
| Jan 2, 2019 | ILMN Illumina, Inc. | Director | Sale+OE | 5,000 | $294.08 | $1,470,381.31 | -31.6% | - | - | |
| May 21, 2018 | ILMN Illumina, Inc. | Director | Sell | 1,000 | $269.80 | $269,802.20 | -7.5% | - | - |